A detailed history of Everpar Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Everpar Advisors LLC holds 2,238 shares of AMGN stock, worth $657,972. This represents 0.37% of its overall portfolio holdings.

Number of Shares
2,238
Previous 2,824 20.75%
Holding current value
$657,972
Previous $882 Million 18.28%
% of portfolio
0.37%
Previous 0.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$309.38 - $337.38 $181,296 - $197,704
-586 Reduced 20.75%
2,238 $721 Million
Q2 2024

Jul 18, 2024

BUY
$262.75 - $319.31 $87,233 - $106,010
332 Added 13.32%
2,824 $882 Million
Q1 2024

Apr 22, 2024

SELL
$268.87 - $324.56 $409,220 - $493,980
-1,522 Reduced 37.92%
2,492 $709 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $1.03 Million - $1.16 Million
4,014 New
4,014 $1.16 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Everpar Advisors LLC Portfolio

Follow Everpar Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everpar Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Everpar Advisors LLC with notifications on news.